Amicus Therapeutics

Amicus Therapeutics company information, Employees & Contact Information

We are a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. Amicus is the Latin word for friend. This name signifies our collaborative approach to developing medicines by incorporating the patient perspective every step of the way. Our company was founded by an entrepreneur who embarked on a life-long journey to transform the lives of those living with devastating conditions when two of his children were diagnosed with a rare disease. That spirit of empathy, compassion, and tenacity permeates our culture and influences all aspects of our approach to advancing cutting-edge technologies. Building on our core beliefs, our mission-focused behaviors help us define and shape our culture; drive performance and innovation; inform development and growth; and attract, energize, and retain the right talent. By championing mission-dedication, innovation, performance, and integrity, we are united by our passion for making a difference and committed to pushing ideas as far and as fast as possible. Our global footprint spans over 20 countries, including our global headquarters in Princeton, NJ and international headquarters in Marlow, UK. Additional international office locations include Australia, Canada, France, Japan, Germany, Italy, The Netherlands, and Spain. More information about Amicus and our career opportunities can be found at www.amicusrx.com.

Company Details

Employees
616
Founded
-
Address
47 Hulfish St, Princeton,new Jersey 08542,united States
Phone
(609)662-200
Email
in****@****srx.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Princeton, New Jersey
Looking for a particular Amicus Therapeutics employee's phone or email?

Amicus Therapeutics Questions

News

Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025 - Sahm

Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025 Sahm

Amicus Therapeutics (NASDAQ: FOLD) sets results call for Nov. 4 at 8:30 a.m. ET - Stock Titan

Amicus Therapeutics (NASDAQ: FOLD) sets results call for Nov. 4 at 8:30 a.m. ET Stock Titan

Amicus Therapeutics Sets Date for Q2 Earnings: Key Updates Expected from Rare Disease Pipeline - Stock Titan

Amicus Therapeutics Sets Date for Q2 Earnings: Key Updates Expected from Rare Disease Pipeline Stock Titan

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2025 - GlobeNewswire

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2025 GlobeNewswire

Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference GlobeNewswire

Top Amicus Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant